|
Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate with pandemic adjuvant system
|
24 February 2020 |
|
FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States
|
20 February 2020 |
|
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
|
05 February 2020 |
|
GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture
|
06 August 2019 |
|
Nucala (mepolizumab) gains FDA approval for two new self-administration options
|
07 June 2019 |
|
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
|
05 December 2018 |
|
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
|
13 April 2018 |
|
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business
|
27 March 2018 |
|
GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy Ellipta
|
23 November 2017 |
|
GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles
|
28 November 2016 |